Synthesis and biological activity of some structural analogs of platelet-activating factor (PAF-acether). 1981

M Ténce, and E Michel, and E Coeffier, and J Polonsky, and J J Godfroid, and J Benveniste

Platelet-activating factor (PAF-acether), a mediator of anaphylaxis and inflammation, is a 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine. Some analogs of PAF-acether were prepared by total synthesis or by partial synthesis from commercially available phospholipids and tested for platelet aggregating activity. This study indicated that the ether linkage at the position 1 of sn-glycerol and the short acyl chain at position 2 are structural features required for biological activity.

UI MeSH Term Description Entries
D008244 Lysophosphatidylcholines Derivatives of PHOSPHATIDYLCHOLINES obtained by their partial hydrolysis which removes one of the fatty acid moieties. Lysolecithin,Lysolecithins,Lysophosphatidylcholine
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

M Ténce, and E Michel, and E Coeffier, and J Polonsky, and J J Godfroid, and J Benveniste
January 1981, Biochimie,
M Ténce, and E Michel, and E Coeffier, and J Polonsky, and J J Godfroid, and J Benveniste
December 1982, Agents and actions,
M Ténce, and E Michel, and E Coeffier, and J Polonsky, and J J Godfroid, and J Benveniste
January 1989, Advances in prostaglandin, thromboxane, and leukotriene research,
M Ténce, and E Michel, and E Coeffier, and J Polonsky, and J J Godfroid, and J Benveniste
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
M Ténce, and E Michel, and E Coeffier, and J Polonsky, and J J Godfroid, and J Benveniste
January 1986, Bulletin europeen de physiopathologie respiratoire,
M Ténce, and E Michel, and E Coeffier, and J Polonsky, and J J Godfroid, and J Benveniste
December 1981, Agents and actions,
M Ténce, and E Michel, and E Coeffier, and J Polonsky, and J J Godfroid, and J Benveniste
January 1985, Die Pharmazie,
M Ténce, and E Michel, and E Coeffier, and J Polonsky, and J J Godfroid, and J Benveniste
January 1988, Progress in clinical and biological research,
M Ténce, and E Michel, and E Coeffier, and J Polonsky, and J J Godfroid, and J Benveniste
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
M Ténce, and E Michel, and E Coeffier, and J Polonsky, and J J Godfroid, and J Benveniste
December 1980, Agents and actions,
Copied contents to your clipboard!